HOME >> MEDICINE >> NEWS
New drug shows promise for saving lives from heart failure

ATLANTA, Nov. 10 -- A new drug for heart failure saves lives and reduces symptoms, according to a study presented today at the American Heart Association Scientific Sessions.

The new drug, called omapatrilat, is a member of a new class of compounds called vasopeptidase inhibitors.

The results of this study, combined with others, suggest that the use of omapatrilat may reduce deaths and hospitalizations from congestive heart failure by as much as 30 percent, says Jean-Lucien Rouleau, M.D., director of cardiology, Mount Sinai Hospital Association at the University Health Network of Toronto, Canada. "It's a potential breakthrough in the treatment of congestive heart failure."

Congestive heart failure is a condition in which the heart can't pump enough blood to meet the needs of other organs in the body. It occurs in hearts that are damaged or overworked after a heart attack, high blood pressure, heart valve disease, congenital defects or infection of the heart or its valves. Drugs used to treat heart failure include digitalis, which increases the heart's pumping action; diuretics, which help eliminate the buildup of fluid in the body's tissues; and vasodilators, which expand blood vessels, allowing blood to flow more easily and making the heart's work easier and more efficient.

Among the vasodilators is a class of drugs know as angiotensin converting enzyme (ACE) inhibitors, which interfere with the body's production of angiotensin, a chemical that causes arteries to constrict.

The problem with ACE inhibitors, according to Rouleau, is that they do not work on all substances in the body that promote abnormal constriction of arteries, which is characteristic of heart failure.

The new drug works in two ways. Like conventional ACE inhibitors, it blocks the action of angiotensin, inhibiting the constrictive action of this substance. But omapatrilat also neutralizes a substance called neutral endopeptidase, resulting in blood vessels rel
'"/>

Contact: Carole Bullock
caroleb@heart.org
214-706-1279
American Heart Association
9-Nov-1999


Page: 1 2 3

Related medicine news :

1. Study shows promise in identifying kidney failure
2. Study shows patch therapy may be as effective as oral medications
3. Study shows soy is well accepted in school lunches
4. Chronic pain treatments more effective when taken together, new study shows
5. UW study shows blacks and Latinos are more satisfied with physicians of the same race
6. Vaccine against childhood pneumonia shows promise
7. UW research shows risk factors for relapse among health care professionals who abuse drugs
8. Study shows use of budesonide reduced the risk of asthma related events by 40% in children
9. New technique shows promise for improved straightening of crooked nose
10. Chemical decoy shows promise for slowing Alzheimers by acting as decoy
11. Study shows risk of cardiac death after radiation for breast cancer has dramatically decreased

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New drug shows promise for saving lives from heart failure

(Date:4/21/2015)... One of the most difficult aspects ... food cravings. Many diets end badly due to dieters’ ... Some attempt to eat more often throughout the day, ... regular intervals. While this approach does work for many, ... after a meal. For those who are having trouble ...
(Date:4/21/2015)... (PRWEB) April 21, 2015 The ... of Science in Health Informatics to answer the ... data into a meaningful, comprehensive wellness profile for ... critical to the development and implementation of health ... administrative, clinical, financial and managerial operations in the ...
(Date:4/21/2015)... April 21, 2015 As nationally ... involved in various components of breast reconstruction research ... , "Breast reconstruction research continues to significantly ... Despite recent advances, many unanswered questions remain requiring ... with optimal results," says Dr. Oscar Ochoa emphasizing ...
(Date:4/21/2015)... (PRWEB) April 21, 2015 CALNOC, the ... Burnes Bolton, DrPH, RN, FAAN, will keynote their upcoming ... in Long Beach, CA on October 26, 2015. ... the American Organization of Nurse Executives (AONE) and the ... president of the American Academy of Nursing and the ...
(Date:4/21/2015)... 2015 Dr. Zain Kadri, a Beverly ... infographic that takes a close look at the rise of ... which appears on both Dr. Kadri’s website and RedOrbit ... in the Age of the Selfie.” According to Dr. Kadri, ... to a variety of A-list patients, the trend of taking ...
Breaking Medicine News(10 mins):Health News:Diet Doc Introduces New Neuro Balance, A Proprietary Diet Aid to Help Dieters Eliminate Food Cravings 2Health News:Diet Doc Introduces New Neuro Balance, A Proprietary Diet Aid to Help Dieters Eliminate Food Cravings 3Health News:The University of Scranton Launches Online MS in Health Informatics 2Health News:The University of Scranton Launches Online MS in Health Informatics 3Health News:Research Performed at PRMA Expands Breast Reconstruction Knowledge 2Health News:Research Performed at PRMA Expands Breast Reconstruction Knowledge 3Health News:Research Performed at PRMA Expands Breast Reconstruction Knowledge 4Health News:Research Performed at PRMA Expands Breast Reconstruction Knowledge 5Health News:Nationally Recognized Nurse Leader Linda Burnes Bolton to Present Keynote Address at CALNOC Conference 2Health News:Beverly Hills Plastic Surgery Expert Dr. Zain Kadri Releases Thought-Provoking New Infographic 2
(Date:4/21/2015)... 21, 2015 /PRNewswire/ -- Mindray Medical International Limited ("Mindray", NYSE: ... of medical devices worldwide, today announced that it will ... Mar 31, 2015 after the U.S. market closes on ... conference call at 8:00 AM on May 12, 2015 ... Beijing/Hong Kong Time). Dial-in details for ...
(Date:4/21/2015)... SAN JOSE, Calif. , April 21, 2015 ... pioneered the use of the iFuse Implant System, ... fusion for certain disorders of the sacroiliac (SI) ... has joined the company,s board of directors effective ... Managing Director for Fidelity Health Insurance Services, LLC.  ...
(Date:4/21/2015)... 2015 Asterias Biotherapeutics, Inc. (NYSE MKT: AST), ... regenerative medicine, today announced that the abstract describing long-term ... the Phase 2 clinical trial of the Company,s autologous  ... for an oral presentation at the 2015 American Society ... in Chicago, Illinois May 29 ...
Breaking Medicine Technology:Mindray to Report 2015 First Quarter Financial Results on May 11, 2015 2SI-BONE, Inc. Announces Appointment of Fidelity Health Insurance Services, LLC's Martin Watson to Board of Directors 2SI-BONE, Inc. Announces Appointment of Fidelity Health Insurance Services, LLC's Martin Watson to Board of Directors 3Asterias Biotherapeutics Announces Phase 2 Clinical Data on Autologous Telomerase-based Dendritic Cell Cancer Vaccine AST-VAC1 Selected for Oral Presentation at the 2015 ASCO Annual Meeting 2Asterias Biotherapeutics Announces Phase 2 Clinical Data on Autologous Telomerase-based Dendritic Cell Cancer Vaccine AST-VAC1 Selected for Oral Presentation at the 2015 ASCO Annual Meeting 3
Cached News: